Atezolizumab in Combination with Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients with Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
September 30, 2017
End Date
December 31, 2022
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
September 30, 2017
End Date
December 31, 2022